Drug discovery > Target Discovery Products & Reviews
Products, services, reviews and techniques used in the identification and validation of the disease-causing target genes and proteins.
Selected Filters:
C.SIGHT™ 2.0 - Single Cell Isolation
CYTENANext-generation label-free single-cell isolation for cell line development.
NexION® 5000 Multi-Quadrupole ICP Mass Spectrometer
PerkinElmerThe first ICP-MS in its category to boast four quads, delivering performance to the power of four
MPS 320™ Microwave Digestion System
PerkinElmerThe perfect microwave for labs of all shapes and sizes, and the foundation of great analysis
ClaIR Infrared Microplate Reader
Photonic Solutions LtdExcite your probes at any wavelengths to validate their NIR-II emissions with Photon etc's ClaIR infrared microplate reader.
IRina In Vivo NIR-II Spectral Probe
Photonic Solutions LtdIRina™ is an in vivo NIR-II spectral probe ideal to quantitate bio-photonic emissions and visualize spectral shifting of activity-based sensors in real time.
GFAP Simoa Assay Kit
QuanterixGlial Fibrillary Acidic Protein (GFAP) is a class-III intermediate filament majorly expressed in astrocytic glial cells in the central nervous system. Astrocytes play a variety of key roles in supporting, guiding, nurturing, and signaling neuronal architecture and activity. Monomeric GFAP is about 55kD. It is capable of forming both homodimers and heterodimers; GFAP can polymerize with other type III proteins or with neurofila…
NEUROLOGY 4-PLEX E (Aβ40, Aβ42, GFAP*, Nf-L)
QuanterixThe Simoa Human Neurology 4-Plex E (N4PE) assay simultaneously measures four biomarkers in EDTA plasma and CSF. The targets are Abeta 40 (Aβ40), Abeta 42 (Aβ42), Glial Fibrillary Acidic Protein (GFAP™), and Neurofilament light (Nf-L). Each biomarker has been demonstrated to have significance for the investigation of neurodegeneration and brain injury, and to have utility for monitoring effectiveness of drug discovery and devel…
pTau-181 Biomarker Assay
QuanterixAdvance your neurology research from discovery to the clinic by reliably detecting pTau-181 in plasma, serum, or cerebrospinal fluid (CSF).
NEUROLOGY 2-PLEX B (Nf-L, GFAP*)
QuanterixThe Simoa Human Neurology 2-Plex assay (N2PB) measures two important neurology biomarkers in both cerebrospinal fluid (CSF) and blood. The two targets are neurofilament light (Nf-L) and glial fibrillary acidic protein (GFAP™), which have been studied as indicators of traumatic brain injury (TBI) severity. N2PB has been developed as a 2-Plex version of the Neurology 4-Plex B assay (N4PB). *Banyan GFAP™ is a registered tradem…